Cystic Fibrosis Trial, Recruiting NCT05860803 Sponsor: Mayo Clinic Condition: Cystic Fibrosis
Back to Cystic Fibrosis

Cystic Fibrosis Trial, Recruiting

NCT05860803
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a Mayo Clinic patient who has been diagnosed with Non-Cystic Fibrosis Bronchiectasis (a lung condition causing widened, damaged airways), confirmed through your medical history, breathing tests, and a detailed CT scan.
  • Your condition is currently stable, meaning you have not had a flare-up or changes to your medications in the past three weeks.
  • You are willing and able to give your consent to take part in the study.

Who may not be able to join:

  • You have a serious ongoing illness, a neurological condition, or a bone or joint problem that would make it difficult for you to exercise.
  • You have advanced heart failure.
  • You are currently taking antibiotics.
  • You have had a flare-up of your lung condition within the three weeks before the study starts.
  • You have taken part in a lung rehabilitation program within the six months before the study starts.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
15 January 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in six-minute walk test distance; Change in peak oxygen uptake during maximal incremental exercise test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov